Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
12,111,473
-
Share change
-
-155,612
-
Total reported value
-
$12,653,078
-
Put/Call ratio
-
240%
-
Price per share
-
$1.09
-
Number of holders
-
32
-
Value change
-
-$250,360
-
Number of buys
-
9
-
Number of sells
-
17
Institutional Holders of ACURA PHARMACEUTICALS INC - COM NEW (ACUR) as of Q2 2014
As of 30 Jun 2014,
ACURA PHARMACEUTICALS INC - COM NEW (ACUR) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,111,473 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., VANGUARD GROUP INC, Creative Planning, GEODE CAPITAL MANAGEMENT, LLC, Financial Advisory Service, Inc., NORTHERN TRUST CORP, Adams Hall Wealth Advisors, LLC, Mariner Wealth Advisors, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and BlackRock Fund Advisors.
This page lists
32
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.